Published in Cell Stem Cell on July 08, 2010
Programmed cell death in animal development and disease. Cell (2011) 5.07
Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature (2012) 3.34
Molecular regulation of stem cell quiescence. Nat Rev Mol Cell Biol (2013) 3.07
Unravelling cancer stem cell potential. Nat Rev Cancer (2013) 3.06
Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature (2014) 2.67
FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature (2013) 2.62
Targeted genome editing in human repopulating haematopoietic stem cells. Nature (2014) 2.49
Cell cycle regulation in hematopoietic stem cells. J Cell Biol (2011) 2.48
Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle. Cell Stem Cell (2014) 2.44
DNA damage checkpoints in stem cells, ageing and cancer. Nat Rev Mol Cell Biol (2012) 2.39
Dynamic niches in the origination and differentiation of haematopoietic stem cells. Nat Rev Mol Cell Biol (2011) 2.34
Crypt base columnar stem cells in small intestines of mice are radioresistant. Gastroenterology (2012) 2.31
Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell (2012) 2.26
The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability. Cell (2013) 2.24
Notch signaling is necessary to maintain quiescence in adult muscle stem cells. Stem Cells (2012) 2.10
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2. Cancer Cell (2016) 2.08
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells. Blood (2015) 2.00
Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells. J Exp Med (2011) 1.95
Manifestations and mechanisms of stem cell aging. J Cell Biol (2011) 1.93
Tracking chromatid segregation to identify human cardiac stem cells that regenerate extensively the infarcted myocardium. Circ Res (2012) 1.63
TLR9 ligation in pancreatic stellate cells promotes tumorigenesis. J Exp Med (2015) 1.59
DNA damage response in adult stem cells: pathways and consequences. Nat Rev Mol Cell Biol (2011) 1.57
Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat Med (2014) 1.52
Hematopoietic Stem Cells Count and Remember Self-Renewal Divisions. Cell (2016) 1.50
Thrombopoietin promotes NHEJ DNA repair in hematopoietic stem cells through specific activation of Erk and NF-κB pathways and their target, IEX-1. Blood (2013) 1.47
Inhibition of CDK4/6 protects against radiation-induced intestinal injury in mice. J Clin Invest (2016) 1.43
Integrating physiological regulation with stem cell and tissue homeostasis. Neuron (2011) 1.41
DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions. Proc Natl Acad Sci U S A (2013) 1.37
Uncoupling p53 functions in radiation-induced intestinal damage via PUMA and p21. Mol Cancer Res (2011) 1.34
Impact of genomic damage and ageing on stem cell function. Nat Cell Biol (2014) 1.33
Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner. Blood (2014) 1.32
Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment. Carcinogenesis (2011) 1.26
The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO. Blood (2012) 1.23
Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J Exp Med (2014) 1.18
Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells. Blood (2013) 1.13
Cell biology. The essence of quiescence. Science (2011) 1.12
Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis. Exp Cell Res (2014) 1.11
Differential DNA damage response in stem and progenitor cells. Cell Stem Cell (2010) 1.11
Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer. Cell Stem Cell (2015) 1.11
Stem cells: balancing resistance and sensitivity to DNA damage. Trends Cell Biol (2014) 1.09
The p53 tumor suppressor protein regulates hematopoietic stem cell fate. J Cell Physiol (2011) 1.08
mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells. Leukemia (2013) 1.07
Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injury. Stem Cells (2013) 1.05
Pathophysiology of ocular surface squamous neoplasia. Exp Eye Res (2014) 1.02
Fancd2 is required for nuclear retention of Foxo3a in hematopoietic stem cell maintenance. J Biol Chem (2014) 1.00
A human iPSC model of Ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors. Cell Death Differ (2013) 0.99
Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita. Blood (2012) 0.99
p53 functions in endothelial cells to prevent radiation-induced myocardial injury in mice. Sci Signal (2012) 0.98
Role of p53 in regulating tissue response to radiation by mechanisms independent of apoptosis. Transl Cancer Res (2013) 0.96
Lessons learned about human stem cell responses to ionizing radiation exposures: a long road still ahead of us. Int J Mol Sci (2013) 0.96
Turning a new page on nucleostemin and self-renewal. J Cell Sci (2014) 0.95
Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat Cell Biol (2016) 0.94
Surviving change: the metabolic journey of hematopoietic stem cells. Trends Cell Biol (2014) 0.93
Leukemia and benzene. Int J Environ Res Public Health (2012) 0.93
Stress and stem cells. Wiley Interdiscip Rev Dev Biol (2012) 0.93
HDAC inhibitor confers radiosensitivity to prostate stem-like cells. Br J Cancer (2013) 0.91
Contribution of an aged microenvironment to aging-associated myeloproliferative disease. PLoS One (2012) 0.91
Cancer, stem cells and cancer stem cells: old ideas, new developments. F1000 Med Rep (2011) 0.91
Cellular mechanisms of somatic stem cell aging. Curr Top Dev Biol (2014) 0.90
Stem cells and DNA damage: persist or perish? Cell (2010) 0.89
Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance. Cell Death Differ (2016) 0.88
Context-specific roles for paracrine IL-6 in lymphomagenesis. Genes Dev (2012) 0.88
Tight regulation of ubiquitin-mediated DNA damage response by USP3 preserves the functional integrity of hematopoietic stem cells. J Exp Med (2014) 0.88
Vaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage. J Biol Chem (2012) 0.88
Replication stress caused by low MCM expression limits fetal erythropoiesis and hematopoietic stem cell functionality. Nat Commun (2015) 0.87
Switching roles: the functional plasticity of adult tissue stem cells. EMBO J (2015) 0.87
Critical differences in hematopoiesis and lymphoid development between humans and mice. J Clin Immunol (2012) 0.87
Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA? Exp Hematol (2013) 0.87
To wake up cancer stem cells, or to let them sleep, that is the question. Cancer Sci (2016) 0.87
Aging, Clonality, and Rejuvenation of Hematopoietic Stem Cells. Trends Mol Med (2016) 0.86
Stem cells, progenitor cells, and lineage decisions in the ovary. Endocr Rev (2014) 0.86
Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease. Blood (2016) 0.86
BRCA1 deficiency in skin epidermis leads to selective loss of hair follicle stem cells and their progeny. Genes Dev (2012) 0.86
Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models. Semin Hematol (2013) 0.86
Rejuvenating Bi(d)ology. Oncogene (2012) 0.86
Apurinic/apyrimidinic endonuclease 2 is necessary for normal B cell development and recovery of lymphoid progenitors after chemotherapeutic challenge. J Immunol (2011) 0.85
DNA Damage Response in Hematopoietic Stem Cell Ageing. Genomics Proteomics Bioinformatics (2016) 0.85
Resilient and resourceful: genome maintenance strategies in hematopoietic stem cells. Exp Hematol (2013) 0.85
Lifespan differences in hematopoietic stem cells are due to imperfect repair and unstable mean-reversion. PLoS Comput Biol (2013) 0.85
Genome instability of ageing stem cells--Induction and defence mechanisms. Ageing Res Rev (2015) 0.84
DNA repair: the culprit for tumor-initiating cell survival? Cancer Metastasis Rev (2011) 0.84
Genetic and Epigenetic Mechanisms That Maintain Hematopoietic Stem Cell Function. Stem Cells Int (2015) 0.84
Hedgehog signaling sensitizes glioma stem cells to endogenous nano-irradiation. Oncotarget (2014) 0.84
TGF-β Inhibition Rescues Hematopoietic Stem Cell Defects and Bone Marrow Failure in Fanconi Anemia. Cell Stem Cell (2016) 0.84
Roles of p53 in various biological aspects of hematopoietic stem cells. J Biomed Biotechnol (2012) 0.84
Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis. Elife (2015) 0.83
RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation. Oncotarget (2014) 0.83
The subventricular zone is able to respond to a demyelinating lesion after localized radiation. Stem Cells (2014) 0.83
HIF hits Wnt in the stem cell niche. Nat Cell Biol (2010) 0.83
Mammary Stem Cells and Tumor-Initiating Cells Are More Resistant to Apoptosis and Exhibit Increased DNA Repair Activity in Response to DNA Damage. Stem Cell Reports (2015) 0.82
Bcl2 overexpression rescues the hematopoietic stem cell defects in Ku70-deficient mice by restoration of quiescence. Blood (2014) 0.82
Sirtuins in hematological aging and malignancy. Crit Rev Oncog (2013) 0.82
Loss of PIDD limits NF-κB activation and cytokine production but not cell survival or transformation after DNA damage. Cell Death Differ (2012) 0.82
Impact of Charged Particle Exposure on Homologous DNA Double-Strand Break Repair in Human Blood-Derived Cells. Front Oncol (2015) 0.81
DNA damage responses in cancer stem cells: Implications for cancer therapeutic strategies. World J Biol Chem (2015) 0.81
When stem cells grow old: phenotypes and mechanisms of stem cell aging. Development (2016) 0.80
Omcg1 is critically required for mitosis in rapidly dividing mouse intestinal progenitors and embryonic stem cells. Biol Open (2012) 0.80
[New treatment strategy for adult T-cell leukemia targeting for anti-tumor immunity and a longevity gene-encoded protein]. Yakugaku Zasshi (2011) 0.80
DNA damage response, redox status and hematopoiesis. Blood Cells Mol Dis (2013) 0.80
Characterization of the stem cell niche and its importance in radiobiological response. Semin Radiat Oncol (2013) 0.80
The hallmarks of cancer. Cell (2000) 113.05
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem (2004) 14.93
FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell (2007) 12.33
Hematopoiesis: an evolving paradigm for stem cell biology. Cell (2008) 11.95
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature (2006) 11.90
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med (2004) 11.29
p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer (2009) 9.21
Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature (2007) 7.72
Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet (2008) 7.30
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet (2007) 7.29
Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature (2004) 7.21
Oncogenic transcription factors in the human acute leukemias. Science (1997) 6.45
Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med (2005) 5.68
DNA repair, genome stability, and aging. Cell (2005) 5.52
DNA repair is limiting for haematopoietic stem cells during ageing. Nature (2007) 4.71
p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell (2009) 4.30
Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature (2009) 3.37
Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood (1999) 3.33
The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J Exp Med (2000) 2.67
Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood (2002) 2.44
JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell (2009) 2.41
Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer (2005) 2.30
Modeling oncogenic translocations: distinct roles for double-strand break repair pathways in translocation formation in mammalian cells. DNA Repair (Amst) (2006) 2.03
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Proc Natl Acad Sci U S A (2009) 1.92
Centrosome amplification induced by DNA damage occurs during a prolonged G2 phase and involves ATM. EMBO J (2004) 1.89
DNA repair defects in stem cell function and aging. Annu Rev Med (2005) 1.74
The comet assay: mechanisms and technical considerations. Mutat Res (1996) 1.62
Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia. Blood (2002) 1.54
Aging in the lympho-hematopoietic stem cell compartment. Trends Immunol (2009) 1.47
Hematopoietic stem cell aging: wrinkles in stem cell potential. Stem Cell Rev (2007) 1.35
The effects of x-irradiation on hematopoietic stem cell compartments in the mouse. Exp Hematol (1991) 1.17
Variations in radiation sensitivity and repair among different hematopoietic stem cell subsets following fractionated irradiation. Blood (1995) 1.10
Multipotent hematopoietic cells susceptible to alternative double-strand break repair pathways that promote genome rearrangements. Genes Dev (2007) 1.10
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood (2009) 23.52
FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell (2007) 12.33
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature (2008) 10.12
Revised international prognostic scoring system for myelodysplastic syndromes. Blood (2012) 8.12
HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell (2008) 8.01
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood (2009) 5.72
Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet (2002) 5.55
Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science (2002) 5.47
In response. Spine (Phila Pa 1976) (2014) 4.87
Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev (2003) 4.71
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet (2004) 4.45
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood (2003) 4.15
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol (2012) 3.88
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci U S A (2003) 3.46
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci U S A (2008) 3.13
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci U S A (2007) 3.00
The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells. Cell Stem Cell (2008) 2.88
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood (2003) 2.76
Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell (2008) 2.67
FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature (2013) 2.62
Bad-deficient mice develop diffuse large B cell lymphoma. Proc Natl Acad Sci U S A (2003) 2.54
CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. Blood (2012) 2.51
Cell cycle regulation in hematopoietic stem cells. J Cell Biol (2011) 2.48
Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell (2013) 2.46
Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood (2004) 2.42
JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell (2009) 2.41
New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors. Cell (2006) 2.34
MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. Cancer Cell (2003) 2.33
Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood (2007) 2.30
Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat Genet (2006) 2.10
IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. Cancer Cell (2011) 2.05
MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility. Blood (2008) 1.98
c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations. Blood (2005) 1.96
K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells. Blood (2006) 1.93
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch. Proc Natl Acad Sci U S A (2006) 1.89
Centrosome amplification induced by DNA damage occurs during a prolonged G2 phase and involves ATM. EMBO J (2004) 1.89
Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia. Cancer Cell (2006) 1.88
Cancer predisposition and hematopoietic failure in Rad50(S/S) mice. Genes Dev (2002) 1.87
A quasi-Newton acceleration for high-dimensional optimization algorithms. Stat Comput (2011) 1.80
High-throughput mapping of origins of replication in human cells. EMBO Rep (2007) 1.75
Oncogenic Kras initiates leukemia in hematopoietic stem cells. PLoS Biol (2009) 1.67
DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell (2011) 1.67
Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke. Arch Phys Med Rehabil (2004) 1.66
MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia. Oncogene (2002) 1.62
Extensive genomic polymorphism within Mycobacterium avium. J Bacteriol (2004) 1.61
Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia. Cancer Cell (2012) 1.61
Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Proc Natl Acad Sci U S A (2002) 1.57
Deconstructing Survivin: comprehensive genetic analysis of Survivin function by conditional knockout in a vertebrate cell line. J Cell Biol (2008) 1.54
Decreased urinary beta-defensin-1 expression as a biomarker of response to arsenic. Toxicol Sci (2008) 1.54
Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia. Cancer Cell (2006) 1.53
DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. Cancer Res (2010) 1.49
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun (2012) 1.49
Molecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells. PLoS One (2010) 1.46
A critical role for Apc in hematopoietic stem and progenitor cell survival. J Exp Med (2008) 1.42
DNA damage induces Chk1-dependent centrosome amplification. EMBO Rep (2007) 1.39
Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies. Wiley Interdiscip Rev Syst Biol Med (2011) 1.37
Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome. Blood (2007) 1.33
Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. Am J Clin Pathol (2007) 1.31
Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK. Mol Microbiol (2005) 1.29
Loss of centrioles causes chromosomal instability in vertebrate somatic cells. J Cell Biol (2013) 1.28
A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657. Blood (2002) 1.25
Haploinsufficiency of Apc leads to ineffective hematopoiesis. Blood (2010) 1.21
ERK8, a new member of the mitogen-activated protein kinase family. J Biol Chem (2002) 1.21
Acquisition of Hrs, an essential component of phagosomal maturation, is impaired by mycobacteria. Mol Cell Biol (2004) 1.20
Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J Exp Med (2014) 1.18
Chronic versus acute myelogenous leukemia: a question of self-renewal. Cancer Cell (2004) 1.18
Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like disease. Blood (2006) 1.17
Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes. Leuk Res (2006) 1.16
Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia. Proc Natl Acad Sci U S A (2002) 1.16
Evidence that the Pim1 kinase gene is a direct target of HOXA9. Blood (2007) 1.16
Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia. J Exp Med (2010) 1.15
Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. J Clin Oncol (2013) 1.15
Pre-replication complex proteins assemble at regions of low nucleosome occupancy within the Chinese hamster dihydrofolate reductase initiation zone. Nucleic Acids Res (2010) 1.13
Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation. Cancer Discov (2013) 1.13
Validation of MdmX as a therapeutic target for reactivating p53 in tumors. Genes Dev (2011) 1.11
JunB inhibits proliferation and transformation in B-lymphoid cells. Blood (2003) 1.10
Activation of Wnt/β-catenin protein signaling induces mitochondria-mediated apoptosis in hematopoietic progenitor cells. J Biol Chem (2012) 1.10
Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice. Blood (2013) 1.10
MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia. Proc Natl Acad Sci U S A (2012) 1.09
Therapy-related myeloid leukaemia: a model for leukemogenesis in humans. Chem Biol Interact (2005) 1.09
Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia. Chem Biol Interact (2009) 1.08
Prognosis and therapy when acute promyelocytic leukemia and other "good risk" acute myeloid leukemias occur as a therapy-related myeloid neoplasm. Mediterr J Hematol Infect Dis (2011) 1.07
Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility. Blood (2009) 1.06
Activated Gs signaling in osteoblastic cells alters the hematopoietic stem cell niche in mice. Blood (2012) 1.05
Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies. Blood (2006) 1.05
Stem cells assessed. Nat Rev Mol Cell Biol (2012) 1.05
The role of late/slow replication of the FRA16D in common fragile site induction. Genes Chromosomes Cancer (2004) 1.05
Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors. Cancer Res (2002) 1.04
Cancer stem cells are everywhere. Nat Med (2009) 1.03
β-Catenin induces T-cell transformation by promoting genomic instability. Proc Natl Acad Sci U S A (2013) 1.03
Common fragile sites are characterized by histone hypoacetylation. Hum Mol Genet (2009) 1.02
miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia. Proc Natl Acad Sci U S A (2013) 1.01
Involvement of centrosome amplification in radiation-induced mitotic catastrophe. Cell Cycle (2007) 1.01
Roles of vertebrate Smc5 in sister chromatid cohesion and homologous recombinational repair. Mol Cell Biol (2011) 1.01